.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Argus Health
Teva
Novartis
Merck
Mallinckrodt
Cantor Fitzgerald
Colorcon
UBS
Julphar

Generated: July 24, 2017

DrugPatentWatch Database Preview

Rifapentine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rifapentine and what is the scope of rifapentine freedom to operate?

Rifapentine
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for Generic Name: rifapentine

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list54
Clinical Trials: see list34
Patent Applications: see list2,521
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rifapentine at DailyMed

Pharmacology for Ingredient: rifapentine

Ingredient-typeRifamycins
Drug ClassRifamycin Antimycobacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
PRIFTIN
rifapentine
TABLET;ORAL021024-001Jun 22, 1998RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Chubb
McKinsey
McKesson
Chinese Patent Office
Cipla
Merck
Harvard Business School
Boehringer Ingelheim
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot